| 000 | 01519 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515150957.0 | ||
| 264 | 0 | _c20090130 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1553-7374 | ||
| 024 | 7 |
_a10.1371/journal.ppat.1000226 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGanesh, Vannakambadi K | |
| 245 | 0 | 0 |
_aA structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. _h[electronic resource] |
| 260 |
_bPLoS pathogens _cNov 2008 |
||
| 300 |
_ae1000226 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCoagulase _xmetabolism |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aPeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aStaphylococcus aureus |
| 700 | 1 | _aRivera, Jose J | |
| 700 | 1 | _aSmeds, Emanuel | |
| 700 | 1 | _aKo, Ya-Ping | |
| 700 | 1 | _aBowden, M Gabriela | |
| 700 | 1 | _aWann, Elisabeth R | |
| 700 | 1 | _aGurusiddappa, Shivasankarappa | |
| 700 | 1 | _aFitzgerald, J Ross | |
| 700 | 1 | _aHöök, Magnus | |
| 773 | 0 |
_tPLoS pathogens _gvol. 4 _gno. 11 _gp. e1000226 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.ppat.1000226 _zAvailable from publisher's website |
| 999 |
_c18498598 _d18498598 |
||